|
Volumn 37, Issue 4, 2005, Pages 1757-1759
|
The pathologic impact of tacrolimus on protocol biopsy in renal transplant patients with basiliximab-based immunosuppression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CALCINEURIN INHIBITOR;
CREATININE;
CYCLOSPORIN A;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ADULT;
CHOLECYSTITIS;
CLINICAL ARTICLE;
COHORT ANALYSIS;
CONFERENCE PAPER;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
CYTOMEGALOVIRUS INFECTION;
DEMOGRAPHY;
DRUG EFFICACY;
DRUG FATALITY;
FEMALE;
FEVER;
HOSPITAL DISCHARGE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INFLAMMATION;
KIDNEY BIOPSY;
KIDNEY FAILURE;
KIDNEY FUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MALE;
PATHOLOGY;
PNEUMONIA;
PRIORITY JOURNAL;
PYELONEPHRITIS;
ANTIBODIES, MONOCLONAL;
BIOPSY;
CREATININE;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MALE;
METHYLPREDNISOLONE;
RECOMBINANT FUSION PROTEINS;
RETROSPECTIVE STUDIES;
TACROLIMUS;
|
EID: 20344383759
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.03.138 Document Type: Conference Paper |
Times cited : (6)
|
References (5)
|